Highlights Sumitomo Metal Mining (“SMM”) confirms Nano One as a key technology partner as it advances its growth strategy for ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback